Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
2022 · Blood · 2,785 citations
https://doi.org/10.1182/blood.2022016867
C
Christoph Röllig
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
516
Papers
16.5K
Citations
58
h-index
164
i10-index
Christoph Röllig is an academic researcher from Städtisches Klinikum Dresden. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Multiple Myeloma Research and Treatments. The author has an h-index of 58, co-authored 439 publications.
ORCID: 0000-0002-3791-0548Papers by this author
worksSorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)
2020 · Journal of Clinical Oncology · 538 citations
https://doi.org/10.1200/jco.19.03345
Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System
2011 · Journal of Clinical Oncology · 262 citations
https://doi.org/10.1200/jco.2010.32.8500
How I treat hyperleukocytosis in acute myeloid leukemia
2015 · Blood · 226 citations
https://doi.org/10.1182/blood-2014-10-551507
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
2020 · Blood Cancer Journal · 153 citations
https://doi.org/10.1038/s41408-020-00357-4
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
2016 · Blood Cancer Journal · 82 citations
https://doi.org/10.1038/bcj.2016.46
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat